These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7685975)

  • 21. Human autoantibodies and monoclonal antibody KHRI-3 bind to a phylogenetically conserved inner-ear-supporting cell antigen.
    Disher MJ; Ramakrishnan A; Nair TS; Miller JM; Telian SA; Arts HA; Sataloff RT; Altschuler RA; Raphael Y; Carey TE
    Ann N Y Acad Sci; 1997 Dec; 830():253-65. PubMed ID: 9616684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of inner ear disease autoantibodies by immunoblotting.
    Cao MY; Gersdorff M; Deggouj N; Warny M; Tomasi JP
    Mol Cell Biochem; 1995 May; 146(2):157-63. PubMed ID: 7565645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum antibody to inner ear proteins in patients with progressive hearing loss. Correlation with disease activity and response to corticosteroid treatment.
    Moscicki RA; San Martin JE; Quintero CH; Rauch SD; Nadol JB; Bloch KJ
    JAMA; 1994 Aug 24-31; 272(8):611-6. PubMed ID: 8057517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can unilateral, progressive or sudden hearing loss be immune-mediated in origin?
    Atturo F; Colangeli R; Bandiera G; Barbara M; Monini S
    Acta Otolaryngol; 2017 Aug; 137(8):823-828. PubMed ID: 28296514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial.
    Harris JP; Weisman MH; Derebery JM; Espeland MA; Gantz BJ; Gulya AJ; Hammerschlag PE; Hannley M; Hughes GB; Moscicki R; Nelson RA; Niparko JK; Rauch SD; Telian SA; Brookhouser PE
    JAMA; 2003 Oct; 290(14):1875-83. PubMed ID: 14532316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoimmune sensorineural hearing loss: is it still a clinical diagnosis?
    Mathews J; Rao S; Kumar BN
    J Laryngol Otol; 2003 Mar; 117(3):212-4. PubMed ID: 12648380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The localization and specificity of guinea pig inner ear antigenic epitopes.
    Cao MY; Gersdorff M; Deggouj N; Tomasi JP
    J Laryngol Otol; 1995 Jan; 109(1):19-23. PubMed ID: 7533202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune-mediated inner ear disease: 10-year experience.
    Broughton SS; Meyerhoff WE; Cohen SB
    Semin Arthritis Rheum; 2004 Oct; 34(2):544-8. PubMed ID: 15505770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoimmune inner ear disease: results of therapy.
    McCabe BF
    Adv Otorhinolaryngol; 1991; 46():78-81. PubMed ID: 1927720
    [No Abstract]   [Full Text] [Related]  

  • 30. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
    Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methotrexate therapy for autoimmune hearing loss: a preliminary report.
    Sismanis A; Thompson T; Willis HE
    Laryngoscope; 1994 Aug; 104(8 Pt 1):932-4. PubMed ID: 8052076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Congenital heart block and immune mediated sensorineural hearing loss: possible cross reactivity of immune response.
    Bason C; Pagnini I; Brucato A; Maestroni S; Puccetti A; Lunardi C; Cimaz R
    Lupus; 2017 Jul; 26(8):835-840. PubMed ID: 27913750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sudden sensorineural hearing loss: a case report supporting the immunologic theory.
    Werneck AL; Gurgel LC; de Mello LM; de Albuquerque GQ
    Arq Neuropsiquiatr; 2003 Dec; 61(4):1018-22. PubMed ID: 14762610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recovery from repeated sudden hearing loss with corticosteroid use in the presence of an acoustic neuroma.
    Berenholz LP; Eriksen C; Hirsh FA
    Ann Otol Rhinol Laryngol; 1992 Oct; 101(10):827-31. PubMed ID: 1416637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune-mediated sensorineural hearing loss with or without endolymphatic hydrops: a clinical and experimental approach.
    Veldman JE
    Ann N Y Acad Sci; 1997 Dec; 830():179-86. PubMed ID: 9616677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody reactivity to heat shock protein 70 and inner ear-specific proteins in patients with idiopathic sensorineural hearing loss.
    Tebo AE; Szankasi P; Hillman TA; Litwin CM; Hill HR
    Clin Exp Immunol; 2006 Dec; 146(3):427-32. PubMed ID: 17100761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical associations of serum antiendothelial cell antibodies in patients with sudden sensorineural hearing loss.
    Cadoni G; Agostino S; Manna R; De Santis A; Fetoni AR; Vulpiani P; Ottaviani F
    Laryngoscope; 2003 May; 113(5):797-801. PubMed ID: 12792313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of ciclosporin in steroid-responsive sudden sensorineural hearing loss.
    McClelland L; Powell RJ; Birchall J
    Acta Otolaryngol; 2005 Dec; 125(12):1356-60. PubMed ID: 16303687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Binding of serum immunoglobulins to human inner ear tissue in inner ear hearing loss: methodologic limits].
    Gebbers JO; Altermatt HJ; Arnold W; Laissue JA; Pfaltz CR
    HNO; 1987 Dec; 35(12):487-91. PubMed ID: 3323147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of systemic high-dose dexamethasone therapy for idiopathic sudden sensorineural hearing loss.
    Egli Gallo D; Khojasteh E; Gloor M; Hegemann SC
    Audiol Neurootol; 2013; 18(3):161-70. PubMed ID: 23446332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.